Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2

Numerous neutralizing antibodies that target SARS-CoV-2 have been reported, and most directly block binding of the viral Spike receptor-binding domain (RBD) to angiotensin-converting enzyme II (ACE2). Here, we deliberately exploit non-neutralizing RBD antibodies, showing they can dramatically assist...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Shion A. Lim, Josef A. Gramespacher, Katarina Pance, Nicholas J. Rettko, Paige Solomon, Jing Jin, Irene Lui, Susanna K. Elledge, Jia Liu, Colton J. Bracken, Graham Simmons, Xin X. Zhou, Kevin K. Leung, James A. Wells
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis Group 2021-01-01
Saila:mAbs
Gaiak:
Bispecific
neutralizing antibody
knob-in-hole
COVID-19
SARS-CoV-2
Sarrera elektronikoa:https://www.tandfonline.com/doi/10.1080/19420862.2021.1893426
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak